TISSIUM
Created in 2013
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
683 10,398Global tags
Activities
Technologies
Entity types
Location
74 Rue du Faubourg Saint-Antoine, 75012 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 123
SIREN
793166299Engaged corporates
11
7 5Added in Motherbase
3 years, 1 month ago
biotech Value proposition
Biomorphic Programmable Polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Medical Device, MedTech, Synthetic Polymers, Tissue Reconstruction, and InnovationOriginal language
Biomorphic Programmable Polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Tissue Reconstruction Solutions | TISSIUM Biomorphic Programmable Polymers
TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
https://tissium.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 19 Nov 2023 | | |
 KLESIA Insurance | KLESIA Insurance | Other 12 Jun 2023 13 Jul 2023 | | |
 CMA CGM Transportation, Logistics, Supply Chain and Storage | CMA CGM Transportation, Logistics, Supply Chain and Storage | Other 16 Apr 2023 | | |
 Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique Government Administration | Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique Government Administration | Other 22 Feb 2023 | | |
 Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 21 Dec 2023 | | |
 PYMNTS Online Audio and Video Media | PYMNTS Online Audio and Video Media | Other 21 Aug 2022 | | |
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 10 Oct 2022 | | |
 ZEBOX Startup accelerator & VC, Venture Capital and Private Equity Principals | ZEBOX Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 8 May 2023 | | |
 SUEZ Environment, Environmental Services | SUEZ Environment, Environmental Services | Other 22 Oct 2019 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Capitalistic Partnership Not event 24 May 2023 | | |